Augustine Therapeutics
Developer of therapeutic drugs designed to treat neuromuscular and neurodegenerative diseases. The company's drugs have the potential to protect from nerve degeneration and promote peripheral myelin r...
Valuation
$73.5M
Market implied
Share Price
N/A
Total Raised
$93.4M
Last Round
N/A